Crossmark

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy

Crossref DOI link: https://doi.org/10.1186/s12885-019-5557-9

Published Online: 2019-04-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Park, Hyunkyung

Youk, Jeonghwan

Shin, Dong-Yeop

Hong, Junshik

Kim, Inho

Kim, Nam Joong

Lee, Jeong-Ok

Bang, Soo-Mee

Yoon, Sung-Soo

Park, Wan Beom

Koh, Youngil
License Information

Text and Data Mining valid from 2019-04-16
More Information

Article History

Received: 25 October 2018

Accepted: 31 March 2019

First Online: 16 April 2019

Ethics approval and consent to participate

: This study was approved by the institutional review board at Seoul National University Hospital (IRB; H-1412-022-631) and was conducted in accordance with the guidelines of the Declaration of Helsinki for biomedical research. Informed written consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interest.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.